Menu

Statera Biopharma, Inc. STAB

Full chart Compare
Set alert

Price alert · STAB

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 9, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.0001 52-week range 0.0266
YTD
-33.33%
1 year
+100.00%

STAB revenue history

Revenue is income from the company’s ordinary business activities.

1,487,036 USD

FY 2021 · Period ended

Coverage: stale. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

FY 2004: 636,341USDFY 2005: 1,138,831USDFY 2006: 1,708,214USDFY 2007: 2,018,558USDFY 2008: 4,705,597USDFY 2009: 14,345,908USDFY 2010: 15,331,567USDFY 2011: 8,790,209USDFY 2012: 3,570,710USDFY 2013: 8,487,966USDFY 2014: 3,701,899USDFY 2015: 2,708,225USDFY 2016: 3,518,402USDFY 2017: 1,948,362USDFY 2018: 1,138,187USDFY 2019: 1,113,421USDFY 2020: 0USDFY 2021: 1,487,036USD

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20212021-12-311,487,0361,487,036Not meaningful
FY 20202020-12-310-1,113,421-100.00%
FY 20192019-12-311,113,421-24,766-2.18%
FY 20182018-12-311,138,187-810,175-41.58%
FY 20172017-12-311,948,362-1,570,040-44.62%
FY 20162016-12-313,518,402810,17729.92%
FY 20152015-12-312,708,225-993,674-26.84%
FY 20142014-12-313,701,899-4,786,067-56.39%
FY 20132013-12-318,487,9664,917,256137.71%
FY 20122012-12-313,570,710-5,219,499-59.38%
FY 20112011-12-318,790,209-6,541,358-42.67%
FY 20102010-12-3115,331,567985,6596.87%
FY 20092009-12-3114,345,9089,640,311204.87%
FY 20082008-12-314,705,5972,687,039133.12%
FY 20072007-12-312,018,558310,34418.17%
FY 20062006-12-311,708,214569,38350.00%
FY 20052005-12-311,138,831502,49078.97%
FY 20042004-12-31636,341Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2025-01-04T21:02:59.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.